Business
Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing
Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of nearly RMB 300 million, a sharp 44% year-over-year (YoY) increase, signaling the initial success of its globalized full-industry-chain strategy and positioning it to become the most innovative player in the global assisted reproduction field. As socie
About this update from Suzhou Basecare Medical Corp. Ltd. Class H
[{"type":"text","content":"SUZHOU, China, March 31, 2025 /PRNewswire/ -- Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of nearly RMB 300 million, a sharp 44% year-over-year (YoY) increase, signaling the initial success of its globalized full-industry-chain strategy and positioning it to become the most innovative player in the global assisted reproduction field. As societies grapple with fertility challenges and high childcare costs, China has integrated assisted reproductive services into its national healthcare system and accelerated childcare subsidy policies. Concurrently, the U.S. White House issued an executive order to strengthen fertility healthcare, mandating commercial insurance plans to cover in vitro fertilization (IVF) treatments and expanding fertility welfare policies.","length":972,"tagName":"p"},{"type":"text","content":"44% Revenue Growth: Building a Full-Industry-Chain Ecosystem in Reproductive Health ","length":83,"tagName":"p"},{"type":"text","content":"Against a backdrop of heightened policy support for fertility, the assisted reproduction industry has entered a strategic growth phase. As a leader in the field, Basecare Medical has leveraged its first-mover advantages in genetic testing, embryo culture, andrology diagnostics, and cryopreservation to establish a closed-loop technological ecosystem across the entire assisted reproduction value chain, emerging as one of China's few industrial-scale benchmark enterprises.","length":478,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":237,"url":"https://media.zenfs.com/en/prnewswire.com/1df69ed8312477dbd1da2fd6b6720840"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jaFemjTvL.KGebBy9rqHMQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQxODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/1df69ed8312477dbd1da2fd6b6720840","width":400,"height":237}},"href":"https://mma.prnewswire.com/media/2653899/image_1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Basecare's 2024 financial results highlight accelerated growth and a maturing product p...
More updates from Suzhou Basecare Medical Corp. Ltd. Class H